Xiaotong Lin

机构：Tongji University, Guangzhou University of Chinese Medicine, Army Medical University, Sun Yat-sen University, National University of Singapore, Shanghai Jiao Tong University, Guangdong Pharmaceutical University, Chinese Academy of Sciences, Harbin Institute of Technology, Fudan University, Nanfang Hospital, Shanghai Institute of Materia Medica, Southwest Hospital, Southern Medical University · ORCID：0009-0009-9984-0141

发表论文 83 篇 · 总被引 3136 次 · h-index 23

代表论文

• IPSC-derived CAR-NK cells for cancer immunotherapy (2023 · Biomedicine & Pharmacotherapy · 被引 78)
• Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice (2023 · Experimental & Molecular Medicine · 被引 32)
• Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice (2023 · Military Medical Research · 被引 31)
• Radiotherapy enhances the anti-tumor effect of CAR-NK cells for hepatocellular carcinoma (2024 · Journal of Translational Medicine · 被引 30)
• Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma (2024 · Experimental & Molecular Medicine · 被引 26)
• Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice (2023 · Cell Reports · 被引 18)